


K2B Therapeutics Email Formats
Biotechnology Research • 238 Main Street, Cambridge, United States • 1-10 Employees
Key Contacts at K2B Therapeutics
Jay Kim
Co-Founder
Saeho Chong
Chief Executive Officer
Michelle Kim
Director Of Operations
Company overview
| Headquarters | 238 Main Street, Cambridge, MA 02142, US |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 1-10 |
About K2B Therapeutics
K2B Therapeutics is developing protein-drug/siRNA conjugates with the potential for tumor-agnostic treatment of cancer. Our team believes that K2B's conjugates will revolutionize cancer therapeutics and address significant unmet need. The foundational technology was developed at KIST (Korea Institute of Science and Technology).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
K2B Therapeutics has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
K2B Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



